[HTML][HTML] Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach

RS Huang, S Duan, SJ Shukla, EO Kistner… - The American Journal of …, 2007 - cell.com
Cisplatin, a platinating agent commonly used to treat several cancers, is associated with
nephrotoxicity, neurotoxicity, and ototoxicity, which has hindered its utility. To gain a better …

Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach

RS Huang, S Duan, SJ Shukla, EO Kistner… - American Journal of …, 2007 - experts.umn.edu
Cisplatin, a platinating agent commonly used to treat several cancers, is associated with
nephrotoxicity, neurotoxicity, and ototoxicity, which has hindered its utility. To gain a better …

[引用][C] Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach

RS HUANG, S DUAN, SJ SHUKLA… - American journal of …, 2007 - pascal-francis.inist.fr
Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a
genomewide approach CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

[引用][C] Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach

H RS - Am J Hum Genet, 2007 - cir.nii.ac.jp
Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a
genomewide approach | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …

[HTML][HTML] Identification of Genetic Variants Contributing to Cisplatin-Induced Cytotoxicity by Use of a Genomewide Approach

RS Huang, S Duan, SJ Shukla, EO Kistner… - The American Journal of …, 2007 - Elsevier
Cisplatin, a platinating agent commonly used to treat several cancers, is associated with
nephrotoxicity, neurotoxicity, and ototoxicity, which has hindered its utility. To gain a better …

[PDF][PDF] Identification of Genetic Variants Contributing to Cisplatin-Induced Cytotoxicity by Use of a Genomewide Approach

RS Huang, S Duan, SJ Shukla, EO Kistner… - The American Journal …, 2007 - core.ac.uk
Cisplatin, a platinating agent commonly used to treat several cancers, is associated with
nephrotoxicity, neurotoxicity, and ototoxicity, which has hindered its utility. To gain a better …

Identification of Genetic Variants Contributing to Cisplatin-Induced Cytotoxicity by Use of a Genomewide Approach

RS Huang, S Duan, SJ Shukla, EO Kistner… - The American Journal of …, 2007 - infona.pl
Cisplatin, a platinating agent commonly used to treat several cancers, is associated with
nephrotoxicity, neurotoxicity, and ototoxicity, which has hindered its utility. To gain a better …

Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach.

RS Huang, S Duan, SJ Shukla, EO Kistner… - American Journal of …, 2007 - europepmc.org
Cisplatin, a platinating agent commonly used to treat several cancers, is associated with
nephrotoxicity, neurotoxicity, and ototoxicity, which has hindered its utility. To gain a better …

Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach

RS Huang, S Duan, SJ Shukla… - … journal of human …, 2007 - pubmed.ncbi.nlm.nih.gov
Cisplatin, a platinating agent commonly used to treat several cancers, is associated with
nephrotoxicity, neurotoxicity, and ototoxicity, which has hindered its utility. To gain a better …

[HTML][HTML] Identification of Genetic Variants Contributing to Cisplatin-Induced Cytotoxicity by Use of a Genomewide Approach

RS Huang, S Duan, SJ Shukla, EO Kistner… - American Journal of …, 2007 - ncbi.nlm.nih.gov
Cisplatin, a platinating agent commonly used to treat several cancers, is associated with
nephrotoxicity, neurotoxicity, and ototoxicity, which has hindered its utility. To gain a better …